stella
beta
Study of Venetoclax and Azacitidine in Advanced BCR-ABL Negative Myeloproliferative Neoplasms — Stella
Recruiting
Back to Myeloproliferative Neoplasm trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(1 site)
Canada
Princess Margaret Cancer Centre, Toronto, Ontario
View full record on ClinicalTrials.gov